MANREMYC is a “spin off” of the Institut for Biomedical Research Germans Trias i Pujol (IGTP) with the mission to eradicate tuberculosis (TB) by reducing its risk of development with a unique and revolutionary product, Nyaditum resae® (NR) based on the most updated technology and a solid scientific background.
|Employees (est.) (Sept 2020)||7||(+40%)|
MANREMYC has 282 Twitter Followers. The number of followers has increased 3.4% quarter over quarter
When was MANREMYC founded?
MANREMYC was founded in 2013.
Who are MANREMYC key executives?
MANREMYC's key executives are PrPere-Joan Cardona, Isabel Amat and Cris Vilaplana.
How many employees does MANREMYC have?
MANREMYC has 7 employees.
Who are MANREMYC competitors?
Competitors of MANREMYC include Opiant Pharmaceuticals, Mylan and Horizon Therapeutics.
Where is MANREMYC headquarters?
MANREMYC headquarters is located at Carrer d'Urgell, 26, Manresa.
Where are MANREMYC offices?
MANREMYC has an office in Manresa.
How many offices does MANREMYC have?
MANREMYC has 1 office.
Receive alerts for 300+ data fields across thousands of companies